Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fasting Condition

NCT01578252 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Fasting State

Interventions

DRUG: Ondansetron Tablets USP 8 mg
DRUG: Ondansetron Hydrochloride

Sponsor

IPCA Laboratories Ltd.